Rhythm Files for IPO
Rhythm, a Boston, Mass.-based biopharmaceutical company developing peptide therapeutics that address gastrointestinal diseases and genetic deficiencies that result in metabolic disorders, filed a registration statement with the U.S. Securities and Exchange Commission (SEC) relating to an initial public offering. The number of shares to be offered and the price range for the offering have not […]